Megan Huizenga - Publications
Affiliations: | 2014- | Pharmacology | Georgetown University, Washington, DC |
Year | Citation | Score | |||
---|---|---|---|---|---|
2020 | Culjat M, Huizenga MN, Forcelli PA. Age-dependent anticonvulsant actions of perampanel and brivaracetam in the methyl-6,7-dimethoxy-4-ethyl-beta-carboline-3-carboxylate (DMCM) model of seizures in developing rats. Pharmacological Reports : Pr. PMID 33210244 DOI: 10.1007/s43440-020-00189-w | 0.694 | |||
2019 | Huizenga MN, Sepulveda-Rodriguez A, Forcelli PA. Preclinical safety and efficacy of cannabidivarin for early life seizures. Neuropharmacology. 148: 189-198. PMID 30633929 DOI: 10.1016/J.Neuropharm.2019.01.002 | 0.693 | |||
2018 | Huizenga MN, Forcelli PA. Neuroprotective Action of the CB1/2 Receptor Agonist, WIN 55,212-2, against DMSO but Not Phenobarbital-Induced Neurotoxicity in Immature Rats. Neurotoxicity Research. PMID 30141144 DOI: 10.1007/s12640-018-9944-9 | 0.659 | |||
2018 | Huizenga MN, Fureman BE, Soltesz I, Stella N. Proceedings of the Epilepsy Foundation's 2017 Cannabinoids in Epilepsy Therapy Workshop. Epilepsy & Behavior : E&B. PMID 29908905 DOI: 10.1016/j.yebeh.2018.05.016 | 0.452 | |||
2017 | Queenan BN, Dunn RL, Santos VR, Feng Y, Huizenga MN, Hammack RJ, Vicini S, Forcelli PA, Pak DTS. Kappa opioid receptors regulate hippocampal synaptic homeostasis and epileptogenesis. Epilepsia. PMID 29114861 DOI: 10.1111/Epi.13941 | 0.53 | |||
2017 | Huizenga MN, Wicker E, Beck VC, Forcelli PA. Anticonvulsant effect of cannabinoid receptor agonists in models of seizures in developing rats. Epilepsia. PMID 28691158 DOI: 10.1111/Epi.13842 | 0.644 | |||
Show low-probability matches. |